Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection

Table 1 Demographic and operative data of the enrolled population

	Total	Untreated	Treated	p - value
Patients	574	287	287
Age, yr; Mean (IQR)	62,24 (61,2-63,2)	62,78 (61,9-63,2)	61,61 (61,2-62,6)	0,2281
No Smokers	158	77	81
Smokers	200	133	67	0,778
Former Smokers	216	77	139
Stage				0,513
pTa	284	153	131
Cis	17	8	9
pT1	273	126	147
Grade				0,253
Low Grade	206	119	87
High Grade	368	168	200
Intravesical therapy				0.07
BCG	290	134	156
MytomicinC	284	153	131
SUBGROUPS	Group A	Group B	Group C	p - value
Patients	98	91	98
Age, yr; Mean (IQR)	61,43 (61,2-62,8)	61,31 (61,2-62,4)	62,71 (61,9-63,3)	0,639

IQR = Interquartile Range Group: A = Cardioaspirin; B = Statins; C = Association.

ISSN: 1471-2407